Skip to content

Atropine eye drops to decrease myopia progression in children

Role of atropine 0.01% drops for controlling progression of myopia in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012348
Enrollment
60
Registered
2018-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Myopia

Interventions

Intervention1: 0.01% Atropine eye drop: one drop of eyedrop in each eyes twice a day for 1 year Control Intervention1: 0.5% Carboxymethylcellulose eye drop: one drop of eyedrop in each eyes twice a da

Sponsors

Department of ophthalmology
Lead Sponsor
Department of ophthalmology
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: patient diagnosed with progressive myopia Normal ocular health other than myopia Informed consent Willing to follow-up

Exclusion criteria

Exclusion criteria: 1.allergy to atropine. 2.previous eye surgery or trauma. 3.previous use of contact lenses , bifocals or other form of treatment for myopia. 4.any cause for visual impairment other than myopia( glaucoma, cataract,Amblyopia,Strabismus ) 5.Previous or concurrent use of contact lenses, bifocals, progressive addition lenses or other forms of treatment (including atropine) for myopia 6.History of cardiac , neurologic or significant respiratory diseases. Unwilling to give consent/ follow-up

Design outcomes

Primary

MeasureTime frame
To study role of Atropine 0.01% drops for controlling progression of Myopia in childrenTimepoint: 2 weeks 3 months 6 months 9 months 1 year

Secondary

MeasureTime frame
To study side effects of lose dose 0.01% Atropine in children with progressive MyopiaTimepoint: 2 weeks 3 months 6 months 9 months 1 year

Countries

India

Contacts

Public ContactDrsiddharth sharma
bansalrk@hotmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026